Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of 3 Months Daily Treatment With Selective Serotonin Reuptake Inhibitor (SSRI, Fluoxetine) on Motor Rehabilitation After Ischemic Stroke. FLAME Trial

NCT00657163 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT00657163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00657163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of 3 Months Daily Treatment With Selective Serotonin Reuptake Inhibitor (SSRI, Fluoxetine) on Motor Rehabilitation After Ischemic Stroke. FLAME Trial
Lead sponsor
University Hospital, Toulouse
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2005
Completion date
December 31, 2010
Enrollment
100 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, motor impairment